Characteristics and treatment patterns among patients with HER2-amplified advanced/metastatic colorectal cancer (mCRC): A clinical-genomic database study

被引：2

作者：

Strickler, J. H. ^{[1
]}

Hsu, L-I. ^{[2
]}

DeBusk, K. ^{[2
]}

Wright, P. ^{[2
]}

Stecher, M. ^{[3
]}

Siadak, M. ^{[4
]}

Palanca-Wessels, M. C. ^{[3
]}

Yu, J. ^{[5
]}

Zhang, N. ^{[6
]}

Espenschied, C. R. ^{[7
]}

Lang, K. ^{[6
]}

Bekaii-Saab, T. ^{[8
]}

机构：

[1] Duke Canc Ctr, Div Med Oncol, Durham, NC USA

[2] Seagen Inc, Global Hlth Econ & Outcomes Res, Bothell, WA USA

[3] Seagen Inc, Clin Dev, Bothell, WA USA

[4] Seagen Inc, Med Affairs, Bothell, WA USA

[5] Guardant Hlth Inc, Clin Dev, Redwood City, CA USA

[6] Guardant Hlth Inc, Outcomes & Evidence, Redwood City, CA USA

[7] Guardant Hlth Inc, Med Affairs, Redwood City, CA USA

[8] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA

来源：

关键词：

D O I：

10.1016/j.annonc.2021.08.960

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

439P

引用

页码：S554 / S554

页数：1